✨ Medicine Product Details
5 FEBRUARY
NEW ZEALAND GAZETTE
Product:
Infanrix-IPV+Hib
Component One:
Active Ingredients:
- Pertactin 16µg/mL
- Pertussis filamentous haemagglutinin 50µg/mL
- Polio virus type 1 80DAgU/mL
- Polio virus type 2 16DAgU/mL
- Polio virus type 3 64DAgU/mL
- Tetanus toxoid, adsorbed 80IU/mL
Dosage Form:
Suspension for injection
Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium
Component Two:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 20µg/mL
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium
Product:
Infanrix-IPV-Hib (Combination Product) (notification received 6 August 2003)
Component One:
Active Ingredients:
- Detoxified pertussis toxin 50µg/mL
- Diphtheria toxoid, adsorbed 60IU/mL
- Pertactin 16µg/mL
- Pertussis filamentous haemagglutinin 50µg/mL
- Polio virus type 1 80DAgU/mL
- Polio virus type 2 16DAgU/mL
- Polio virus type 3 64DAgU/mL
- Tetanus toxoid, adsorbed 80IU/mL
Dosage Form:
Suspension for injection
Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium
Component Two:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 20µg/mL
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium
Product:
Infanrix-penta
Active Ingredients:
- Diphtheria toxoid, adsorbed 30IU/dose
- Hepatitis B surface antigen, recombinant 10µg/dose
- Pertactin 8µg/dose
- Pertussis filamentous haemagglutinin 25µg/dose
- Pertussis toxoid, adsorbed 25µg/dose
- Polio virus type 1 40DAgU
- Polio virus type 2 8DAgU
- Polio virus type 3 32DAgU
- Tetanus toxoid, adsorbed 40IU/dose
Dosage Form:
Suspension for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium
Product:
Mencevax ACWY vaccine
Active Ingredients:
- Neisseria meningitidis, group A 50µg
- Neisseria meningitidis, Group C 50µg
- Neisseria meningitidis, group W135 50µg
- Neisseria meningitidis, group Y 50µg
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium
Product:
Provera HD
Active Ingredient:
Medroxyprogesterone acetate 100mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Pharmacia Italia SpA, Marino del Tronto, Ascoli Piceno, Italy
269
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 11
Gazette.govt.nz —
NZ Gazette 2004, No 11
✨ LLM interpretation of page content
🏥
Consent to the Distribution of Changed Medicines
(continued from previous page)
🏥 Health & Social Welfare2 February 2004
Medicines Act 1981, Distribution, Changed Medicines, Infanrix-hexa, Infanrix-Hib, Infanrix-IPV, Infanrix-IPV-Hib
🏥 Product Details for Infanrix-IPV+Hib
🏥 Health & Social WelfareMedicine, Vaccine, Product Details, GlaxoSmithKline, Infanrix-IPV+Hib
🏥 Product Details for Infanrix-IPV-Hib (Combination Product)
🏥 Health & Social WelfareMedicine, Vaccine, Product Details, GlaxoSmithKline, Infanrix-IPV-Hib
🏥 Product Details for Infanrix-penta
🏥 Health & Social WelfareMedicine, Vaccine, Product Details, GlaxoSmithKline, Infanrix-penta
🏥 Product Details for Mencevax ACWY vaccine
🏥 Health & Social WelfareMedicine, Vaccine, Product Details, GlaxoSmithKline, Mencevax ACWY
🏥 Product Details for Provera HD
🏥 Health & Social WelfareMedicine, Product Details, Pfizer, Provera HD